Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity

被引:67
作者
Netzel-Arnett, S
Mitola, DJ
Yamada, SS
Chrysovergis, K
Holmbeck, K
Birkedal-Hansen, H
Bugge, TH
机构
[1] NIDCR, Matrix Metalloprot Unit, NIH, Bethesda, MD 20892 USA
[2] NIDCR, Proteases & Tissue Remodeling Unit, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M206354200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinase-14 is required for degradation of fibrillar collagen by mesenchymal cells. Here we show that keratinocytes use an alternative plasminogen and matrix metalloproteinase-13-dependent pathway for dissolution of collagen fibrils. Primary keratinocytes displayed an absolute requirement for serum to dissolve collagen. Dissolution of collagen was abolished in plasminogen-depleted serum and could be restored by the exogenous addition of plasminogen. Both plasminogen activator inhibitor-1 and tissue inhibitor of metalloproteinase blocked collagen dissolution, demonstrating the requirement of both plasminogen activation and matrix metalloproteinase activity for degradation. Cell surface plasmin activity was critical for the degradation process as aprotinin, but not alpha(2)-antiplasmin, prevented collagen dissolution. Keratinocytes with single deficiencies in either urokinase or tissue plasminogen activator retained the ability to dissolve collagen. However, collagen fibril dissolution was abolished in keratinocytes with a combined deficiency in both urokinase and tissue plasminogen activator. Combined, but not single, urokinase and tissue plasminogen activator deficiency also completely blocked the activation of the fibrillar collagenase, matrix metalloproteinase-13, by keratinocytes. The activation of matrix metalloproteinase-13 in normal keratinocytes was prevented by plasminogen activator inhibitor-1 and aprotinin but not by tissue inhibitor of metalloproteinase-1 and -2, suggesting that plasmin activates matrix metalloproteinase-13 directly. We propose that plasminogen activation facilitates keratinocyte-mediated collagen breakdown via the direct activation of matrix metalloproteinase-13 and possibly other fibrillar collagenases.
引用
收藏
页码:45154 / 45161
页数:8
相关论文
共 78 条
[1]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[2]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[3]  
2-Z
[4]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[5]  
BAKER MS, 1990, CANCER RES, V50, P4676
[6]   Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation [J].
Balbín, M ;
Fueyo, A ;
Knäuper, V ;
López, JM ;
Alvarez, J ;
Sánchez, LM ;
Quesada, V ;
Bordallo, J ;
Murphy, G ;
López-Otín, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10253-10262
[7]   CLONING, NUCLEOTIDE SEQUENCING AND EXPRESSION OF CDNAS ENCODING MOUSE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR [J].
BELIN, D ;
VASSALLI, JD ;
COMBEPINE, C ;
GODEAU, F ;
NAGAMINE, Y ;
REICH, E ;
KOCHER, HP ;
DUVOISIN, RM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 148 (02) :225-232
[8]   A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen [J].
Benbow, U ;
Schoenermark, MP ;
Mitchell, TI ;
Rutter, JL ;
Shimokawa, K ;
Nagase, H ;
Brinckerhoff, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25371-25378
[9]   Plasminogen activators direct reorganization of the liver lobule after acute injury [J].
Bezerra, JA ;
Currier, AR ;
Melin-Aldana, H ;
Sabla, G ;
Bugge, TH ;
Kombrinck, KW ;
Degen, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :921-929
[10]  
BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140